🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
The purpose of this study is to investigate the ability of alvimopan to red...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-03-08
Trial ID
NCT03352414
The present clinical study aims to verify the effectiveness and safety of t...
Status
Completed
Location
IRCCS Don Carlo Gnocchi
Start Date
2021-12-01
Trial ID
NCT05130814
The purpose of this study is to confirm the safety and efficacy of oral tin...
Status
Completed
Location
Duke University School of Medicine
Start Date
2005-01
Trial ID
NCT00229216
Treatments Being Tested
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Status
Completed
Location
Institut Bergonié
Start Date
2022-02-09
Trial ID
NCT04807816
Treatments Being Tested
This research study is an extension on a study already preregistered NCT042...
Status
Completed
Location
University of Iceland
Start Date
2020-09-08
Trial ID
NCT04342416
Treatments Being Tested
This is a clinical study protocol for a single centre, randomized, double b...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-23
Trial ID
NCT01449838
Treatments Being Tested
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-29
Trial ID
NCT07582315